As expected, compared with the control group, the expression of myogenic factors was significantly decreased in the DM1 group, with MyoD representing early-stage and MyoG and Mef2C representing middle and late stage (34, 35). This evidence concerns the gene MYOD1 and myotonic dystrophy type 1.